| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.34▼ | 2.34▼ | 2.34▼ | 2.37▼ | 2.35▼ |
| MA10 | 2.35▼ | 2.35▼ | 2.35▼ | 2.34▼ | 2.12▲ |
| MA20 | 2.36▼ | 2.37▼ | 2.37▼ | 2.37▼ | 1.82▲ |
| MA50 | 2.38▼ | 2.35▼ | 2.33▲ | 2.06▲ | 1.41▲ |
| MA100 | 2.32▲ | 2.39▼ | 2.39▼ | 1.69▲ | 1.51▲ |
| MA200 | 2.41▼ | 2.25▲ | 2.10▲ | 1.45▲ | 3.05▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.008▼ | -0.008▼ | -0.024▼ | 0.051▲ |
| RSI | 46.166▼ | 47.486▼ | 47.642▼ | 52.609▲ | 64.213▲ |
| STOCH | 45.139 | 28.472 | 28.472 | 60.039 | 65.438 |
| WILL %R | -62.500 | -66.667 | -66.667 | -47.826 | -41.447 |
| CCI | -46.667 | -55.947 | -59.464 | 17.372 | 76.224 |
| CDL | $TXMD Doji Candlestick Pattern Detected | Set Alert |
|
Thursday, June 05, 2025 02:44 PM
Shares of TherapeuticsMD Inc. TXMD slipped 2.67% to $2.19 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.59% to ...
|
|
Friday, May 30, 2025 02:33 PM
This was the stock's second consecutive day of losses.
|
|
Tuesday, April 11, 2017 07:06 AM
While the company itself is still not completely clear on the specific deficiencies the FDA mentions in the letter, the market has certainly assumed the worst, sending shares of TherapeuticsMD down 28 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/02/26 | 2.31 | 2.40 | 2.28 | 2.32 | 17,076 |
| 17/02/26 | 2.36 | 2.39 | 2.29 | 2.30 | 48,000 |
| 13/02/26 | 2.43 | 2.51 | 2.33 | 2.36 | 22,200 |
| 12/02/26 | 2.44 | 2.45 | 2.34 | 2.42 | 66,400 |
| 11/02/26 | 2.37 | 2.44 | 2.28 | 2.43 | 41,500 |
| 10/02/26 | 2.26 | 2.53 | 2.26 | 2.38 | 32,288 |
| 09/02/26 | 2.27 | 2.54 | 2.26 | 2.48 | 63,300 |
| 06/02/26 | 2.23 | 2.32 | 2.19 | 2.29 | 31,400 |
| 05/02/26 | 2.19 | 2.36 | 2.1209 | 2.19 | 49,408 |
| 04/02/26 | 2.36 | 2.37 | 2.13 | 2.25 | 88,000 |
|
|
||||
|
|
||||
|
|